EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Oncological impact of cystoscopic findings in non‐muscle ‐invasive bladder cancer: a meta‐analysis

Takafumi Yanagisawa iD, Fahad Quhal iD, Tatsushi Kawada iD, Hadi Mostafaei iD, Reza Sari Motlagh iD, Ekaterina Laukhtina iD, Pawel Rajwa iD, Markus von Deimling iD, Alberto Bianchi, Maximilian Pallauf iD, Muhammad Majdoub, Benjamin Pradere iD und 7 weitere

BJU International · 2023

DOI: 10.1111/bju.15944 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJU International, 2023. Verfasst von Takafumi Yanagisawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the association between cystoscopic findings and oncological outcomes in patients with non‐muscle‐invasive bladder cancer (NMIBC) given that the oncological impact of quantity and quality assessment of tumours with cystoscopy has not been well verified.

Methods

Multiple databases were queried in May 2022 for studies investigating the association of oncological outcomes, such as recurrence‐free (RFS), progression‐free (PFS), and cancer‐specific survival (CSS), with cystoscopic findings, including multiplicity, size, and gross appearance of tumours in patients with NMIBC.

Results

Overall, 73 studies comprising 28 139 patients were eligible for the meta‐analysis. Tumour multiplicity was associated with worse RFS (pooled hazard ratio [HR] 1.61, 95% confidence interval [CI] 1.48–1.74) and PFS (pooled HR 1.44, 95% CI 1.18–1.76) in NMIBC patients (including both Ta and T1). Tumour size (≥3 cm) was associated with worse RFS (pooled HR 1.97, 95% CI 1.69–2.30) and PFS (pooled HR 1.81, 95% CI 1.52–2.15) in NMIBC patients. In patients with T1 bladder cancer (BCa), tumour multiplicity and size (≥3 cm) were also associated with worse RFS, PFS and CSS. By contrast, among patients treated with bacillus Calmette‐Guérin (BCG), tumour multiplicity was not associated with worse RFS, and tumour size (≥3 cm) was not associated with worse PFS. Sessile tumours were associated with worse RFS (pooled HR 2.14, 95% CI 1.52–3.01) and PFS (pooled HR 2.17, 95% CI 1.42–3.32) compared to pedunculated tumours. Compared to papillary tumours, solid tumours were associated with worse RFS (pooled HR 1.84, 95% CI 1.25–2.72) and PFS (pooled HR 3.06, 95% CI 2.31–4.07) in NMIBC patients, and CSS in T1 BCa patients (pooled HR 2.32, 95% CI 1.63–3.30).

Conclusions

Cystoscopic findings, including tumour multiplicity, size, and gross appearance, strongly predict oncological outcomes in NMIBC patients. Cystoscopic visual features can help in the decision‐making process regarding the timeliness and extent of tumour resection as well as future management such as intravesical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsHumansProportional Hazards ModelsCystoscopyBCG VaccineAdministration, IntravesicalNeoplasm Recurrence, LocalNeoplasm InvasivenessRetrospective Studies

Stichwörter der Autor:innen

#BladderCancer#blcsm#uroonccystoscopygross appearancemultiplicitynon-muscle-invasive bladder cancerprogressionrecurrencesize

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Takafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, Hadi Mostafaei, Reza Sari Motlagh, Ekaterina Laukhtina, Pawel Rajwa, Markus von Deimling, Maximilian Pallauf, Benjamin Pradere, Mohammad Abufaraj, Marco Moschini, Jun Miki, Takahiro Kimura, Shahrokh F Shariat

Zitieren

APA

Yanagisawa, T., Quhal, F., Kawada, T., Mostafaei, H., Motlagh, R. S., Laukhtina, E., Rajwa, P., von Deimling, M., Bianchi, A., Pallauf, M., Majdoub, M., Pradere, B., Abufaraj, M., Moschini, M., Karakiewicz, P. I., Iwatani, K., Miki, J., Kimura, T., & Shariat, S. F. (2023). Oncological impact of cystoscopic findings in non‐muscle ‐invasive bladder cancer: a meta‐analysis. BJU International. https://doi.org/10.1111/bju.15944

Vancouver

Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Motlagh RS, Laukhtina E, et al. Oncological impact of cystoscopic findings in non‐muscle ‐invasive bladder cancer: a meta‐analysis. BJU International. 2023. doi:10.1111/bju.15944

BibTeX
@article{Yanagisawa2023,
  author = {Yanagisawa, Takafumi and Quhal, Fahad and Kawada, Tatsushi and Mostafaei, Hadi and Motlagh, Reza Sari and Laukhtina, Ekaterina and Rajwa, Pawel and von Deimling, Markus and Bianchi, Alberto and Pallauf, Maximilian and Majdoub, Muhammad and Pradere, Benjamin and Abufaraj, Mohammad and Moschini, Marco and Karakiewicz, Pierre I and Iwatani, Kosuke and Miki, Jun and Kimura, Takahiro and Shariat, Shahrokh F},
  title = {Oncological impact of cystoscopic findings in non‐muscle ‐invasive bladder cancer: a meta‐analysis},
  journal = {BJU International},
  year = {2023},
  doi = {10.1111/bju.15944}
}
Kostenlos starten →